HC Wainwright restated their buy rating on shares of Greenwich LifeSciences (NASDAQ:GLSI – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $36.00 price objective on the stock. HC Wainwright also issued estimates for Greenwich LifeSciences’ Q4 2024 earnings at ($0.17) EPS, FY2024 earnings at ($0.75) EPS, […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was acquired at an average cost of $19.08 per share, with a total value of $57,240.00. Following the purchase, the chief executive officer now owns 5,350,777 shares of […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel purchased 3,000 shares of the stock in a transaction dated Monday, April 1st. The stock was acquired at an average cost of $19.08 per share, for a total transaction of $57,240.00. Following the completion of the transaction, the chief executive officer now owns 5,350,777 […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 12,700 shares of the stock in a transaction on Thursday, February 15th. The stock was bought at an average price of $11.07 per share, with a total value of $140,589.00. Following the completion of the acquisition, the chief executive officer now directly owns […]
Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Free Report) CEO Snehal Patel acquired 12,700 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were purchased at an average cost of $11.07 per share, for a total transaction of $140,589.00. Following the acquisition, the chief executive officer now directly owns 5,325,377 shares […]